Tags : Presence

Samsung Biologics Collaborates with APRINOIA Therapeutics to Expand its Presence

Shots: Samsung Biologics entered into an agreement with APRINOIA Therapeutics to develop an anti-tau mAb for treating primary and secondary tauopathies, including PSP and AD APRINOIA will utilize its Ab platform for selecting the candidate and targets specific pathological tau aggregates with novel conformation-dependent epitopes with an aim to slow down disease progression The collaboration […]Read More

Zuellig Pharma Acquires Alliance Pharma (Cambodge) to Bolster its Presence

Shots: Zuellig Pharma acquires Alliance Pharma for enhancing the access to healthcare for Cambodian people by combining their reach and capabilities in Cambodia The focus of the acquisition is to strengthen Zuellig presence in Indochina and allow the company to lead Cambodia’s market With the acquisition, Zuellig Pharma will continue to provide quality service and […]Read More

STADA to Acquire Biopharma’s Pharmaceutical Prescription and Consumer Health Business

Shots: STADA to acquire Biopharma’s pharmaceutical prescription and consumer health business including local manufacturing operations and ~300 new staff. Biopharma will retain its blood plasma-based business and will focus on its development both in Ukraine and outside Ukraine The acquisition will complement STADA’s European growth strategy and allow STADA to become a major pharma player […]Read More

Daiichi Sankyo Acquires Rights for Astellas’ Three Therapies to Boost

Shots: Astellas to receive ~$88.3M as up front for its three products. Daiichi to get rights and obligations, including manufacturing and marketing approvals for Nasea (ramosetron), Perdipine (nicardipine) and Oldeca (barnidipine) from Dec’2019 The focus of the agreement is to strengthen Daiichi’s presence in Asia and to contribute to healthcare in Asia by acquiring two […]Read More